Alpha-santalol, a chemopreventive agent against skin cancer, causes G2/M cell cycle arrest in both p53-mutated human epidermoid carcinoma A431 cells and p53 wild-type human melanoma UACC-62 cells
Open Access
- 3 August 2010
- journal article
- Published by Springer Science and Business Media LLC in BMC Research Notes
- Vol. 3 (1), 220
- https://doi.org/10.1186/1756-0500-3-220
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Effects of alpha-santalol on proapoptotic caspases and p53 expression in UVB irradiated mouse skin.2008
- Chemoprevention by alpha-santalol on UVB radiation-induced skin tumor development in mice.2007
- Chemopreventive effects of -santalol on ultraviolet B radiation-induced skin tumor development in SKH-1 hairless miceCarcinogenesis: Integrative Cancer Research, 2006
- Chemopreventive activity of parthenolide against UVB-induced skin cancer and its mechanismsCarcinogenesis: Integrative Cancer Research, 2004
- Cancer chemoprevention with dietary phytochemicalsNature Reviews Cancer, 2003
- Chemopreventive effects of alpha-santalol on skin tumor development in CD-1 and SENCAR mice.2003
- Cancer prevention – the potential for diet to modulate molecular signallingTrends in Molecular Medicine, 2003
- Skin Cancer Chemoprevention: Strategies to Save Our SkinRecent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 2003
- Chemoprevention of Nonmelanoma Skin Cancer: Experience with a Polyphenol from Green TeaPublished by Springer Science and Business Media LLC ,2003
- Suppression of tumour development by substances derived from the diet—mechanisms and clinical implicationsBritish Journal of Clinical Pharmacology, 1998